Airbus Group SE (AIR)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 192.46 |
|---|---|
| 52-week range | 157.42 – 221.30 |
| Return, 1 month / 3 months | −1.3% / −5.9% |
| Return, 1 year / 3 years | −5.4% / +65.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -27.7% |
| Average daily value traded | 187.71M EUR |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Airbus Group is an aerospace and defence company based in Toulouse, France. It designs and builds commercial aircraft for airlines around the world, including narrowbody and widebody jets. Through its helicopter division it makes civil and military rotorcraft, and its defence and space arm supplies military aircraft, satellites and space systems to governments and institutional customers. The group operates across Europe, with major industrial sites in France, Germany, Spain and the United Kingdom.
Airbus Group SE trades under the code AIR on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Airbus Group SE (AIR) trades on the Euronext Paris in France. It last closed at EUR 192.46 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 81 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.4% and over the last three months it fell 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.7% | ||
| From 52-week high | -12.6% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.9% | ||
| 6-month return | 14.5% | ||
| 12-month return, skipping the last month | -4.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.7% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 187.71M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −1.3% |
| 3 months | −5.9% |
| 6 months | +14.5% |
| 1 year | −5.4% |
| 3 years | +65.6% |
| 5 years | +90.1% |
Signals
| 50-day / 200-day average | 196.09 / 187.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | EUR 3.2000 |
| 22 Apr 2025 | EUR 3.0000 |
| 19 Apr 2024 | EUR 1.8000 |
| 25 Apr 2023 | EUR 1.8000 |
| 19 Apr 2022 | EUR 1.5000 |
| 15 Apr 2019 | EUR 1.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.